Titan Biotech Ltd

Titan Biotech Ltd

Titan Biotech Ltd has fixed the record date as October 23, 2026, for ascertaining the eligibility of shareholders for the allotment of bonus equity shares in the ratio of 1:4. The deemed date of allotment is October 26, 2026.

Titan Biotech Ltd

Titan Biotech Ltd has submitted a certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, confirming the dematerialization of securities for the quarter ended September 30, 2026.

Titan Biotech Ltd

Titan Biotech Ltd has increased its authorized share capital from Rs. 10,00,00,000 to Rs. 10,40,00,000 by creating 20,00,000 new equity shares of Rs. 2 each.

Titan Biotech Ltd

Titan Biotech Ltd has announced the voting results and scrutinizer's report for its 34th Annual General Meeting (AGM), which was held on September 29, 2026. The meeting was conducted through video conferencing, and the resolutions were passed with 100% votes in favor. The company also declared a dividend on its equity shares.

Titan Biotech Ltd

Titan Biotech Ltd held its 34th Annual General Meeting (AGM) on September 29, 2026, through video conferencing. The meeting was attended by directors, key managerial personnel, auditors, and shareholders. The proceedings were in compliance with the Companies Act, 2013, and the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Titan Biotech Ltd

Titan Biotech Ltd has announced the closure of its trading window from October 1, 2026, until 48 hours after the declaration of its unaudited financial results for the quarter and half year ending September 30, 2026, in compliance with SEBI regulations.

Titan Biotech Ltd

Titan Biotech Ltd has announced the submission of a newspaper advertisement regarding the 34th Annual General Meeting (AGM) to be held on September 29, 2026, through Video Conferencing / Other Audio Visual Means.

Titan Biotech Ltd

Titan Biotech Ltd has announced the record date for the final dividend of Rs. 0.50 per equity share for the financial year 2025-26, to be paid after the 34th Annual General Meeting (AGM) subject to approval.

Titan Biotech Ltd

Titan Biotech Ltd has scheduled its 34th Annual General Meeting (AGM) on September 29, 2026, through video conferencing. The record date, book closure date, and e-voting dates have been fixed as September 22, 23, and 29, 2026, respectively.

Titan Biotech Ltd

Titan Biotech Ltd has announced the fixation of Annual General Meeting (AGM) date, record date, book closure date, and e-voting dates for its 34th AGM. The AGM will be held on September 29, 2026, through video conferencing. The record date for determining entitlement to receive the final dividend for the financial year ended March 31, 2026, is September 22, 2026.

Titan Biotech Ltd

Titan Biotech Ltd has recommended a bonus issue of shares in the ratio of 1:4, subject to shareholder approval, and also approved the re-appointment of an independent director and an increase in authorized share capital.

Titan Biotech Ltd

Titan Biotech Ltd has announced the outcome of its Board Meeting held on September 3, 2026, where it considered and approved the issuance of bonus shares to equity shareholders in the ratio of 1:4, increase in authorized share capital, and re-appointment of an independent director. The company has also scheduled its 34th Annual General Meeting for September 29, 2026, and fixed the record date for the purpose of determining members eligible to vote on the resolutions set out in the Notice of the AGM.

Titan Biotech Ltd

Titan Biotech Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 03/09/2026 to consider and approve the proposal of bonus issue, finalize AGM notice, directors report, and other items.

Titan Biotech Ltd

Titan Biotech Ltd has announced the closure of its trading window for all Designated Persons, their Immediate Relatives and Connected Persons until 48 hours after the conclusion of the Board Meeting scheduled to be held on September 03, 2026, to consider the proposal for issue of Bonus Shares.

Titan Biotech Ltd

Titan Biotech Ltd has published unaudited financial results for the quarter ended June 30, 2026, in compliance with Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Titan Biotech Ltd

Titan Biotech Ltd announced its unaudited financial results for the quarter ended June 30, 2026, which were approved by the Board of Directors. The results will be available on the company's website and on BSE Ltd's website.

Titan Biotech Ltd

Titan Biotech Ltd has announced its unaudited financial results for the quarter ended June 2026, with the Board of Directors approving the results at its meeting held on August 13, 2026. The results will be available on the company's website and the BSE Ltd website.

Titan Biotech Ltd

Titan Biotech Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 to consider and approve the standalone and consolidated unaudited financial results for the quarter ended June 30, 2026.

Titan Biotech Ltd

Titan Biotech Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure, effective from July 1, 2026, is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will remain closed until 48 hours after the company declares its unaudited financial results for the quarter ended June 30, 2026. The specific date for the board meeting to approve these results will be communicated later.